AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
On August 5, 2025,
experienced a significant drop of 23.9% in pre-market trading, marking a notable decline in its stock performance.Nuwellis has recently achieved a significant milestone with the first successful outpatient treatment using its Aquadex SmartFlow® ultrafiltration system. This development highlights the company's progress in advancing its medical technology and expanding its treatment capabilities.
Nuwellis is expected to report its earnings for the fiscal quarter ending June 2025 on August 12, 2025, before the market opens. This upcoming earnings report is anticipated to provide insights into the company's financial performance and future outlook.

Get the scoop on pre-market movers and shakers in the US stock market.

Dec.30 2025

Dec.30 2025

Dec.30 2025

Dec.30 2025

Dec.30 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet